Our speaker next Monday 22 June will be Dr Robert Feldman, the Chief Executive Officer of the Kiwi start-up Covid-19 Vaccines Corporation Limited (this will be a Zoom meeting and login details are in the President’s message).  The company has been set up to develop a vaccine candidate using unique nanobead technology developed in New Zealand.  This technology will enable the manufacture of a vaccine much faster and more cost-effectively than by using other methods, as well as avoiding traditional egg-culture and animal cells in its manufacture.  The aim is to complete the first human vaccine trial by the end of 2021.